The Life Science Tools and Diagnostics sector is important for diversification of any biotechnology portfolio. The stocks are less volatile than biopharmaceuticals and less driven by momentum players because the companies are more dependent on financial metrics especially revenue growth. NanoString Technologies (NSTG) develops, manufactures and sells products for both life science research and diagnostic testing markets.
NanoString was incorporated in Delaware in 2003 and is headquartered in Seattle, WA. In 2008, the company launched its first commercial instrument system, the nCounter Analysis System, a system currently used by life science researchers who are performing cancer research, biomarker validation and screening, and validation of nextgen sequencing data. NanoString is pursuing a distributed model where local...
Only subscribers can access this article, which is part of the PRO research library covering 3,581 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: